Speakers

Adam Taylor

Scientist

Defence Science & Technology Laboratory - DSTL

Agnieska Czechowicz

Assistant Professor of Pediatrics

Stanford University School of Medicine

Alain Beck

Senior Director, Biologics CMC & developability

Pierre Fabre

Anand Subramony

Vice President, Antibody Discovery & Protein Engineering, R&D

AstraZeneca

Andre Dumetz

Senior Scientific Investigator

GlaxoSmithKline

Arturo Molina

Chief Medical Officer

Sutro Biopharma

Bob Bayer

Director of CMC Drug Development

Tanabe Research Laboratories

Bob Liu

Senior Scientist

CytomX

Brian Lannutti

Senior Vice President - Research & Development

Velosbio

Brian Mendelsohn

Director, Process Development & Tech Transfer

Ajinomoto Bio-Pharma Services

Christopher Scott

Professor - Pharmaceutical Biosciences

Queen's University Belfast

David Newman

Independent Consultant

Donald Mager

Professor & Vice Chair of Pharmaceutical Sciences

University at Buffalo

Dorota Roberts

Associate Director Technical Product Steward - Biologics

Seagen

Ed Ha

Founding Principal Scientist

AngieX

Elizabeth Love

Senior Scientist - Drug conjugates, Biologics & Analysis

LifeArc

Francesca Zammarchi

Head of Pharmacology

ADC Therapeutics

Futa Mimoto

Research Manager

Chugai Pharmaceuticals

Gareth Thomas

Professor - Experimental Pathology

University of Southampton

Gavin Bennett

Director & Project Leader

Bicycle Therapeutics

Gilles Gallant

Senior Vice President, Global Head of Oncology Development, Oncology R&D

Daiichi Sankyo

Giorgio Salciarini

Technical Business Development Manager

BSP Pharmaceuticals

Gordon Rigg

Principal Consultant

Apex Biologics Consulting

Graham Cotton

Head of Protein Therapeutics

Almac Discovery

Ian Schwartz

Global Biconjugate and Antibody-Drug Conjugates Consultant

Sartorius

Horst Bierau

Senior Scientific Advisor – Head CMC Science & Intelligence

Merck

Jia He

Analyst

Beacon Target Therapies

John Harlan

Senior Principal Research Scientist

AbbVie

John Lambert

Independent Consultant

Attager Consulting

Jon Van Dyck

Scientist

Seagen

Jostein Dahle

Chief Scientific Officer

Nordic Nanovector

Krista Kinneer

Senior Scientist

AstraZeneca

Lolke de haan

Head of Toxicology

ADC Therapeutics

Maria Laura Greco

Marie Curie Research Fellow

AstraZeneca

Marie Leman

Drug Product Team Leader & Tech Transfer Leader

Sanofi

Naresh Jain

President & Chief Executive Officer

NJ Biopharmaceuticals LLC

Nathan Ihle

Vice President - Chemistry, Manufacturing, Controls & Quality

Bolt Biotherapeutics

Nithyanandan Nagercoil

Expert Medical Assessor

Medicines & Healthcare Products Regulatory Agency (MHRA)

Paul Song

Chief Scientific Officer

Genequantum

Phil Howard

Chief Scientific Officer

Spirogen

Rick Powers

Independent Consultant

Robert Straubinger

Professor of Pharmaceutical Sciences

University at Buffalo

Roger Beerli

Chief Scientific Officer

NBE-Therapeutics

Ruud Coumans

Project Leader Antibody-Drug Conjugates

Byondis

Salaheldin Hamed

Pharmacologist

FDA

Sally Ward

Director of Translational Immunology, Centre for Cancer Immunology

University of Southampton

Samuele Cazzamalli

Research Scientist

Philogen

Sean (Xiang) Zheng

Senior Staff Scientist & Head of ADC Conjugation Lab

Regeneron

Shelley Ackerman

Senior Scientist

Bolt Biotherapeutics

Signe Diness Vindeløv

Director, Medical

Genmab

Simon Chivers

Independent Consultant

Steffen Wöll

Principal Scientist

Merck

Steve Conlan

Professor

University of Swansea

Thomas Nittoli

Director, R&D Chemistry Therapeutic Proteins

Regeneron

Toby Eyre

Haematology Consultant

Oxford University Hospitals NHS Foundation Trust

Torbjörn Gräslund

Professor in Medical Protein Technology

KTH Royal Institute of Technology

Ulf Grawunder

Chief Executive Officer & Founder

NBE Therapeutics

Victoria Wei

Associate Director

Johnson & Johnson

Vijay Chudasama

Professor of Organic Chemistry & Chemical Biology

University College London

William Goundry

Principal Scientist

AstraZeneca

Full Event Guide